Overview
Since its inception in 2009, DIA China has become the most influential forum that convenes regulators, industry players, academia, payers and students in the healthcare product development community. The DIA China Annual Meeting has attracted near 3000 professional attendees from China, East Asia and some international locations in year 2019.
In 2020, the DIA China Annual Meeting is about to enter a new era, life-science innovation ecosystem have become vitally active in China attributed to the remarkable China's regulatory reform, the energized returnees in bio-medical R&D field, sufficient government supports and various investment funding opportunities.
DIA China 2020 planned in Suzhou from May 20 to 23 will boast more than 150 exhibiting companies, over 14+ themes, more than 80 sessions and explorable networking opportunities.
Program Chair
 |
Zhengqing LI, PhD R&D Head, MSD China |
Program Honorary Chair
 |
Ruilin SONG Executive President, China Pharmaceutical Innovation and Research Development Association (PhIRDA) |
Program Steering Committee
 |
Shun LU, MD, PhD Director, Shanghai Lung Cancer Center Shanghai Jiaotong University |
 |
Alex XU, PhD Chief Scientist, CDE, NMPA |
 |
Jingsong WANG, MD CEO, Harbour Biomed (HBM) |
 |
Xianglin ZHANG Dean, Yeehong Business School Shenyang Pharmaceutical University |
 |
Ling SU, PhD Professor, Shenyang Pharmaceutical University Venture Partner, Lilly Asia Ventures |
 |
Carol ZHU, MBA Former Managing Director, DIA China |
 |
Tongyan WANG, PhD Senior Vice President and Managing Director, DIA China |
2020 Key Themes Listing
International Advisory Committee
DIA and YOU
DIA China
Beijing | Unit 1607, Tower One, No. 1 Danling Avenue, Haidian District, Beijing 100080, China
T. +86.10.5704.2659
Shanghai | Unit 601, 599 Ling Ling Road, Xu Hui District, Shanghai 200030, China
T. +86.21.6487 6029
T. +86.10.5704.2659 (Customer Service Line)
F. +86.10.5704.2651 | E. China@DIAglobal.org
